We are honored to announce that CONQUER has enrolled its 1,000th participant! 🎉
In 2018, the SRF launched the CONQUER Registry (an acronym for COllaborative National QUality and Efficacy Registry)—a first-of-its-kind nationwide longitudinal scleroderma patient registry and biosample repository aimed at improving care and developing more effective, personalized therapies for systemic sclerosis (scleroderma) patients.
The SRF is all-in for research: this large-scale project is a key component of our multifaceted research program and is critical in advancing developments that can enable more precise and tailored care for individual scleroderma patients. And CONQUER is already generating results—to date, 6 papers have been published based on analysis of data from the registry.
We are excited to announce this huge milestone during Scleroderma Awareness Month. The SRF is grateful to participating institutions and principal investigators who lend their expertise and leadership to make the CONQUER Registry possible.
Interested in participating in CONQUER? Learn more about the project and about how you can get involved.
